Skip to main content
Journal cover image

Prognostic value of predischarge electrocardiographic measurement of infarct size after thrombolysis: insights from GUSTO I Economics and Quality of Life substudy.

Publication ,  Journal Article
Barbagelata, A; Califf, RM; Sgarbossa, EB; Knight, D; Mark, DB; Granger, CB; Armstrong, PW; Elizari, M; Birnbaum, Y; Grinfeld, LR; Ohman, EM ...
Published in: Am Heart J
November 2004

BACKGROUND: Current methods for risk stratification after acute myocardial infarction (MI) include several noninvasive studies. In this cost-containment era, the development of low-cost means should be encouraged. We assessed the ability of an electrocardiogram (ECG) MI-sizing score to predict outcomes in patients enrolled in the Economics and Quality of Life (EQOL) sub study of the Global Utilization of Streptokinase and Tissue plasminogen activator for Occluded coronary arteries -I (GUSTO-I) trial. METHODS: We classified patients by electrocardiographic Selvester QRS score at hospital discharge: those with a score 0-9 versus > or =10. Endpoints were 30-day and 1-year mortality, resource use, and quality-of-life measures. RESULTS: Patients with a QRS score <10 were well-matched with those with QRS score > or =10 with the exception of a trend to more anterior MI in the higher scored group. Patients with QRS score > or =10 had increased risk of death at 30-days (8.9% vs. 2.9% P < .001), and this difference persisted at 1 year (12.6% vs. 5.4%, P = .001). Recurrent chest pain, use of angiography, and angioplasty were similar during follow-up. However, there was a trend toward less coronary bypass surgery in patients with a QRS score > or =10. Readmission rates were higher at 30 days but similar at 1 year. CONCLUSIONS: Stratification of patients after acute MI by a simple measure of MI size identifies populations with different long-term prognoses; patients with a QRS score > or =10 (approximately 30% of the left ventricle infarcted) at discharge have poorer outcomes in both the short- and long-term. The standard 12-lead ECG provides a simple, economical means of risk stratification at discharge.

Duke Scholars

Published In

Am Heart J

DOI

EISSN

1097-6744

Publication Date

November 2004

Volume

148

Issue

5

Start / End Page

795 / 802

Location

United States

Related Subject Headings

  • Tissue Plasminogen Activator
  • Thrombolytic Therapy
  • Survival Analysis
  • Streptokinase
  • Risk Assessment
  • Prognosis
  • Plasminogen Activators
  • Myocardial Infarction
  • Multivariate Analysis
  • Middle Aged
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Barbagelata, A., Califf, R. M., Sgarbossa, E. B., Knight, D., Mark, D. B., Granger, C. B., … GUSTO-1 Investigators. (2004). Prognostic value of predischarge electrocardiographic measurement of infarct size after thrombolysis: insights from GUSTO I Economics and Quality of Life substudy. Am Heart J, 148(5), 795–802. https://doi.org/10.1016/j.ahj.2004.04.046
Barbagelata, Alejandro, Robert M. Califf, Elena B. Sgarbossa, David Knight, Daniel B. Mark, Christopher B. Granger, Paul W. Armstrong, et al. “Prognostic value of predischarge electrocardiographic measurement of infarct size after thrombolysis: insights from GUSTO I Economics and Quality of Life substudy.Am Heart J 148, no. 5 (November 2004): 795–802. https://doi.org/10.1016/j.ahj.2004.04.046.
Barbagelata A, Califf RM, Sgarbossa EB, Knight D, Mark DB, Granger CB, et al. Prognostic value of predischarge electrocardiographic measurement of infarct size after thrombolysis: insights from GUSTO I Economics and Quality of Life substudy. Am Heart J. 2004 Nov;148(5):795–802.
Barbagelata, Alejandro, et al. “Prognostic value of predischarge electrocardiographic measurement of infarct size after thrombolysis: insights from GUSTO I Economics and Quality of Life substudy.Am Heart J, vol. 148, no. 5, Nov. 2004, pp. 795–802. Pubmed, doi:10.1016/j.ahj.2004.04.046.
Barbagelata A, Califf RM, Sgarbossa EB, Knight D, Mark DB, Granger CB, Armstrong PW, Elizari M, Birnbaum Y, Grinfeld LR, Ohman EM, Wagner GS, GUSTO-1 Investigators. Prognostic value of predischarge electrocardiographic measurement of infarct size after thrombolysis: insights from GUSTO I Economics and Quality of Life substudy. Am Heart J. 2004 Nov;148(5):795–802.
Journal cover image

Published In

Am Heart J

DOI

EISSN

1097-6744

Publication Date

November 2004

Volume

148

Issue

5

Start / End Page

795 / 802

Location

United States

Related Subject Headings

  • Tissue Plasminogen Activator
  • Thrombolytic Therapy
  • Survival Analysis
  • Streptokinase
  • Risk Assessment
  • Prognosis
  • Plasminogen Activators
  • Myocardial Infarction
  • Multivariate Analysis
  • Middle Aged